The Chinese stock market is getting wiped out. That tsunami of selling has inflicted heavy technical damage on the Shanghai Composite, says one technician. » Read More
Jim Cramer explains how strong earnings can take the guesswork out of your next investment. » Read More
Jim Cramer races through his take on callers' favorite stocks, including a pharmaceutical play that's ripe for some selling. » Read More
Jim Cramer hears from Peter Horvath, a former Victoria's Secret and American Eagle Outfitters executive, about his new gig as CEO of a cannabis products company. » Read More
Jim Cramer reveals his top "power" players in the information technology space, including consumer tech plays, software giants and a fintech kicker.
Jim Cramer recommends four stocks for investors to start buying as the market's October volatility continues.
Jim Cramer says there's "no cause" for the Federal Reserve to raise interest rates four more times and calls on the central bank to take its time.
"If we start taking out those lows, I think you are going to start seeing some dramatic declines across the board," Altaira Capital Partners' Ralph Acampora says.
Goldman Sachs CEO David Solomon speaks with CNBC's Wilfred Frost about the markets, the U.S. economy and the Federal Reserve, U.S. relations with China and Saudi Arabia, and his transition to the CEO role.
Goldman Sachs CEO David Solomon said Thursday that he believes part of October's steep stock sell-off was the result of programmatic trading.
Goldman was set to send Dina Powell to the conference, but decided against it amid the uproar over journalist Jamal Khashoggi's disappearance, CEO David Solomon said in an interview with CNBC's Wilfred Frost on Thursday.
U.S. companies with significant exposure to overseas markets sank Thursday amid a growing slowdown in the Chinese economy and higher input costs.
The questions you ask a hiring manager are more important than sending a thank-you note afterwards.
As crude hits a one-month low, four market experts weigh in on the biggest risks to the oil market
The recent mini-correction in stocks has been driven mostly by technical factors and should reverse as companies progress through earnings season, according to J.P. Morgan strategists.
In a wild week for the Dow, one corner of the index has proven immune to the worst of the volatility: health care. Dow stocks Pfizer, UnitedHealth and Merck remain within reach of 52-week highs.
Uber, Lyft and Slack are among the tech companies expected to go public next year.
Goldman Sachs warned clients to only buy chipmaker stocks with standalone value, as the firm sees a downturn coming to the semiconductor sector.
Nearly 90 percent of cities hold more people with a bachelor's degree than jobs requiring that education.
Two major homebuilder stock-tracking ETFs, the ITB and the XHB, are on track to post their worst years since 2008 — and some strategists see further downside.